Belvin Marcia
- SEC CIK
- 0001970752
In the past year, 1 open-market sale filing worth $202.2K and no purchases.
Current role at each company
- CTMX CytomX Therapeutics, Inc.SVP, Chief Scientific Officeras of Mar 19, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $202.2K
- 1 filing
- Net
- −$202.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Belvin Marcia as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2026 (view filing) | Mar 17 | 2 days | Belvin MarciaSVP, Chief Scientific Officer | SSale | −31.5K | $6.42 | −$202.2K | −9.5%300.8K after | |
| Jun 17, 2025 (view filing) | Jun 16 | 1 day | Belvin MarciaSVP, Chief Scientific Officer | SSale | −13.9K | $2.69 | −$37.3K | −4.9%272.3K after | |
| Mar 20, 2025 (view filing) | Mar 18 | 2 days | Belvin MarciaSVP, Chief Scientific Officer | SSale | −19.5K | $0.60 | −$11.7K | −7.3%248.6K after | |
| Aug 22, 2024 (view filing) | Aug 20 | 2 days | Belvin MarciaSVP, Chief Scientific Officer | SSale | −4.18K | $1.23 | −$5.14K | −2.3%175.6K after | |
| Mar 21, 2024 (view filing) | Mar 19 | 2 days | Belvin MarciaSVP, Chief Scientific Officer | SSale | −12.8K | $2.09 | −$26.7K | −7.1%168.6K after | |
| Dec 22, 2023 (view filing) | Dec 20 | 2 days | Belvin MarciaSVP, Chief Scientific Officer | SSale | −4.08K | $1.38 | −$5.63K | −2.6%155.1K after | |
| Sep 22, 2023 (view filing) | Sep 22 | Same day | Belvin MarciaSVP, Chief Scientific Officer | SSale | −4.12K | $1.30 | −$5.35K | −2.7%148.0K after |